🇺🇸 FDA
Company

Addex

Addex Therapeutics

ADXN pharma USA

Quick answer

Addex is a pharma company (ADXN) headquartered in GENEVA, V8, USA with 6 tracked pipeline programs.

Pipeline (6)

project

Dipraglurant

Parkinson Disease

Phase 3 · small_molecule · terminated

2 trials project

ADX10059

Gastroesophageal Reflux

Phase 2 · small_molecule · completed

2 trials project

ADX10059

Migraine

Phase 2 · small_molecule · terminated

1 trials project

ADX48621

Parkinson's Disease

Phase 2 · small_molecule · completed

1 trials project

Dipraglurant

Blepharospasm

Phase 2 · small_molecule · completed

1 trials project

ADX48621

Healthy

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 11071729

1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones

Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10071095

1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of n

Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9938270

Mono-phosphate salt of 6-fluoro-2-[4-(pyridin-2-yl)but-3-yn-1-yl]imidazo[1,2A]py

Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9765091

Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modul

Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9737533

1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of p

Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9266834

1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allost

Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9226930

1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of p

Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9132122

1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones

Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)